Feasibility of Comprehensive Genomic Profiling for Biliary Tract Cancer Using Transpapillary Biopsy Samples: A Prospective Study
Journal of Hepato-Biliary-Pancreatic Sciences · 2026-08 · 33 (8) · 615-623
DOI: 10.1002/jhbp.70123 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Hepato-Biliary-Pancreatic Sciences, online erschienen am 06.05.2026. Verfasst von Kazuya Miyamoto und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology and Hepatology, Okayama University Hospital, Okayama, Japan. Hauptthemen laut MEDLINE: Biliary Tract Neoplasms, Gene Expression Profiling. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: JSPS KAKENHI.
Abstract (Originalsprache)
Background
Patients with biliary tract cancer (BTC) often have actionable mutations, and comprehensive genomic profiling (CGP) plays an important role. However, the feasibility of CGP using transpapillary biopsy (TPB) samples remains unclear.
Methods
Thirty patients with suspected BTC based on radiographic imaging were enrolled. Pre‐analytical criteria for CGP suitability were based on the OncoGuide NCC Oncopanel System (NCCOP) and FoundationOne CDx (F1CDx). Each patient underwent six biopsies using an endoscopic introducer: five biopsy samples were preserved as formalin‐fixed paraffin‐embedded (FFPE) samples and one as a fresh frozen (FF) sample. DNA quality indicators were compared between the two groups.
Results
Malignancy was confirmed in 29 patients, and one had a benign biliary stricture. Suitability rate was 31% (9/29) for NCCOP and 3.4% (1/29) for F1CDx. Compared to FFPE samples, FF samples demonstrated significantly higher DNA concentration [ng/μL, interquartile range (IQR)], [0.34 (0.16–0.95) vs. 37.8 (11.6–67.6), p < 0.001] and DNA integrity number (IQR) [7.1 (6.8–7.3) vs. 8.9 (8.3–9), p = 0.021].
Conclusions
Introducer‐assisted multipass TPB may increase the rate of obtaining adequate CGP specimens, but its suitability remains limited and strongly panel dependent. Since FF samples have better DNA quality, establishing a system detailing their use is desirable. Trial Registration ClinicalTrials.gov identifier: UMIN 000049826
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Gastroenterology and Hepatology, Okayama University Hospital, Okayama, Japan.
- Department of Endoscopy, Okayama University Hospital, Okayama, Japan.
- Department of Pathology and Experimental Medicine, Okayama University Hospital, Okayama, Japan.
- Department of Medical Support, Okayama University Hospital, Okayama, Japan.
ORCID-Profile: Kazuyuki Matsumoto, Ryosuke Sato, Motoyuki Otsuka
Förderung
- JSPS KAKENHI
Zitieren
APA
Miyamoto, K., Matsumoto, K., Ohara, T., Fujisawa, M., Inoue, H., Sato, R., Matsumi, A., Fujii, Y., Uchida, D., & Otsuka, M. (2026). Feasibility of Comprehensive Genomic Profiling for Biliary Tract Cancer Using Transpapillary Biopsy Samples: A Prospective Study. Journal of Hepato-Biliary-Pancreatic Sciences, 33(8), 615-623. https://doi.org/10.1002/jhbp.70123
Vancouver
Miyamoto K, Matsumoto K, Ohara T, Fujisawa M, Inoue H, Sato R, et al. Feasibility of Comprehensive Genomic Profiling for Biliary Tract Cancer Using Transpapillary Biopsy Samples: A Prospective Study. Journal of Hepato-Biliary-Pancreatic Sciences. 2026;33(8):615-623. doi:10.1002/jhbp.70123
BibTeX
@article{Miyamoto2026,
author = {Miyamoto, Kazuya and Matsumoto, Kazuyuki and Ohara, Toshiaki and Fujisawa, Masayoshi and Inoue, Hirohumi and Sato, Ryosuke and Matsumi, Akihiro and Fujii, Yuki and Uchida, Daisuke and Otsuka, Motoyuki},
title = {Feasibility of Comprehensive Genomic Profiling for Biliary Tract Cancer Using Transpapillary Biopsy Samples: A Prospective Study},
journal = {Journal of Hepato-Biliary-Pancreatic Sciences},
year = {2026},
volume = {33},
number = {8},
pages = {615--623},
doi = {10.1002/jhbp.70123}
}
EUVIMED